Complexity and Selectivity of γ-Secretase Cleavage on Multiple Substrates: Consequences in Alzheimer’s Disease and Cancer

Article type: Review Article

Authors: Medoro, Alessandro^{a; 1} | Bartollino, Silvia^{a; 1} | Mignogna, Donatella^a | Passarella, Daniela^a | Porcile, Carola^a | Pagano, Aldo^b | Florio, Tullio^c | Nizzari, Mario^c | Guerra, Germano^a | Di Marco, Roberto^a | Intrieri, Mariano^a | Raimo, Gennaro^a | Russo, Claudio^{a; *}

Affiliations: [a] Department of Medicine and Health Sciences “V. Tiberio”, University of Molise, Campobasso, Italy | [b] Department of Experimental Medicine, University of Genoa and Ospedale Policlinico San Martino, IRCCS per l’Oncologia, Genoa, Italy | [c] Department of Internal Medicine and Centre of Excellence for Biomedical Research, University of Genoa, Genoa, Italy

Correspondence: [*] Correspondence to: Prof. Claudio Russo, Department of Medicine and Health Sciences “V. Tiberio”, University of Molise, Via F. De Sanctis, 86100 Campobasso, Italy. Tel.: +39 0874404897; E-mail: claudio.russo@unimol.it.

Note: [1] These authors contributed equally to this work.

Abstract: The processing of the amyloid-β protein precursor (AβPP) by β- and γ-secretases is a pivotal event in the genesis of Alzheimer’s disease (AD). Besides familial mutations on the AβPP gene, or upon its overexpression, familial forms of AD are often caused by mutations or deletions in presenilin 1 (PSEN1) and 2 (PSEN2) genes: the catalytic components of the proteolytic enzyme γ-secretase (GS). The “amyloid hypothesis”, modified over time, states that the aberrant processing of AβPP by GS induces the formation of specific neurotoxic soluble amyloid-β (Aβ) peptides which, in turn, cause neurodegeneration. This theory, however, has recently evidenced significant limitations and, in particular, the following issues are debated: 1) the concept and significance of presenilin’s “gain of function” versus “loss of function”; and 2) the presence of several and various GS substrates, which interact with AβPP and may influence Aβ formation. The latter consideration is suggestive: despite the increasing number of GS substrates so far identified, their reciprocal interaction with AβPP itself, even in the AD field, is significantly unexplored. On the other hand, GS is also an important pharmacological target in the cancer field; inhibitors or GS activity are investigated in clinical trials for treating different tumors. Furthermore, the function of AβPP and PSENs in brain development and in neuronal migration is well known. In this review, we focused on a specific subset of GS substrates that directly interact with AβPP and are involved in its proteolysis and signaling, by evaluating their role in neurodegeneration and in cell motility or proliferation, as a possible connection between AD and cancer.

Keywords: Alzheimer’s disease, AβPP, β-secretase, cancer, cell migration, γ-secretase, LDL receptor, Notch

DOI: 10.3233/JAD-170628

Journal: Journal of Alzheimer's Disease, vol. 61, no. 1, pp. 1-15, 2018